Gritstone bio, Inc. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c16175bc-d636-4d47-b1c9-296e5dd5086c/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-139.6M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-025855 |
| FY 2022 | $-120.4M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-007022 |
| FY 2021 | $-75.2M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-003366 |
| FY 2020 | $-106.0M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-012260 |
| FY 2019 | $-97.9M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-009886 |
| FY 2018 | $-65.6M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-009825 |
| FY 2017 | $-41.8M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-009825 |
| FY 2016 | $-19.0M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-009825 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).